Cleared Traditional

K940817 - TDX/TDXFLX FETAL LUNG MATURITY II

K940817 is an FDA 510(k) clearance for TDX/TDXFLX FETAL LUNG MATURITY II, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code JHF cleared through the Traditional 510(k) pathway after a 351-day FDA review.

K940817 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
351d
Days
Class 2
Risk

K940817 is an FDA 510(k) clearance for the TDX(R)/TDXFLX(R) FETAL LUNG MATURITY II. Classified as Colorimetric Method, Lecithin/sphingomyelin Ratio (product code JHF), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on February 8, 1995 after a review of 351 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1455 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K940817

510(k) Number K940817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 1994
Decision Date February 08, 1995
Days to Decision 351 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
263d slower than avg
Panel avg: 88d · This submission: 351d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHF Device Classification - Class 2, Special Controls

Product Code JHF Colorimetric Method, Lecithin/sphingomyelin Ratio
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1455
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.